By the use of morphology and cytochemistry AML can be subclassified into six groups according to the FAB classification (Bennet et al., 1976) . In most protocols, however, all six subclasses are given the same type of chemotherapy and there appear to be only marginal differences in prognosis between the subclasses and the best prognostic indicator has been the age of the patient (Keating et al., 1980) . We have recently described that analysis of the content of TdT and glucocorticoid receptor in leukaemic cells adds significant prognostic information (Skoog et al., 1982) .
Terminal transferase (TdT) is an enzyme which was originally considered to be a specific marker for lymphoid cells of the T-or pre B-type (Hoffbrand et al., 1977) . AML cells contain in general low or undetectable levels of the enzyme but occasional cases of AML cells with elevated TdT levels have been described (Marcus et al., 1976; Shrivastava et al., 1976) . It (Marks' et al., 1978) . We (Skoog et al., 1982) . This finding was of particular interest since it was the first time that a biochemical parameter with prognostic implications was described for AML.
It was long ago realized that patients with ALL usually respond to glucocorticoid therapy (Shanbrom, 1962; Childrens Cancer Study Group, 1967) . In the case of AML conflicting results have been reported. Approximately 10-15% of the patients responded to glucocorticoid therapy while some patients showed progression on the same therapy (Knospe & Conrad, 1966 (Bell, 1982) .
Measurements of the cellular receptor content in ALL have shown that there is a positive correlation between receptor level and response to treatment with steroids (Lippman et al., 1978) . Furthermore there are indications that the receptor levels in ALL represent a prognostic variable which to some extent is independent of the immunological phenotype. Patients with high receptor content in their leukaemic cells had a long remission contrasting those with low receptor levels who had a shorter remission duration (Lippman et al., 1978) .
In the case of AML the receptor level, as determined by whole cell assay, does not appear to be related to survival or response to chemotherapy (Bell, 1982) . However, in a recent study we reported that there exists a positive correlation between cellular cytosol receptor content and survival in AML (Skoog et al., 1982) .
The present paper extends our previous study of TdT and glucocorticoid receptor as prognostic indicators in AML.
Material and methods Patients
We have studied 52 adult patients with acute myeloid leukemia (AML). Peripheral blood was collected before therapy was started. All the patients were treated according to the protocol of the Leukaemia Group of Central Sweden (LCS). Thirty patients were less than 60 years old and were treated with daunorubicin and cytarabine initially and if complete remission could be established they were given courses of either daunorubicin and cytarabine or cytarabine and thioguanine as maintenance therapy. Twenty-two patients were 60 years or older, and received a somewhat milder initial treatment with thioguanine and cytarabine. A few elderly patients were treated with prednimustine (LEO, Sweden) as well.
Criteria for diagnosis. Classification Our criteria for the diagnosis acute leukaemia were the findings of .50 percent leukaemic cells in the bone marrow or an unequivocal finding of Auer rods. The classification was made according to the FAB classification (Bennet et al., 1976) with slight modifications (Ost et al., 1983) .
Cytochemical methods used for classification, the procedure for isolation of leukaemic cells from peripheral blood and measurements of TdT activity have been published previously (Skoog et al., 1983 Thirty microliters of appropriately diluted (1/1-1/5) antibodies were added to 106 pelleted cells and were incubated for 1 h at 4°C. After washing 3 times, the incubation was repeated with 30 p1 of 1/20 diluted fluorescein isothiocyanate-conjugated F(ab')2 sheep anti-mouse Ig serum preabsorbed with human serum (Natl. Bact. Lab., Stockholm, Sweden).
Immunofluorescent staining of TdT
For immunofluorescent staining (IFL) of TdT, two affinity purified rabbit antisera were used, one was kindly provided by Dr Bollum and the other was purchased from PL Biochemical (S.T. Goar, FRG). The thawed leukaemic cells were Ficoll-Paque separated prior to cytocentrifugation. The slides were air-dried, fixed in cold methanol (30 min at 4°C) and dehydrated in PBS. Five microliters rabbit anti-TdT was added and the slides incubated (30 min at 20°C) in a humidified chamber. The slides were washed in PBS (30 min) before repeating the staining procedure with purified sheep antirabbit Ig labelled with FITC (Natl. Bact. Lab., Stockholm, Sweden) for 30 min at 200C. After repeated washing in PBS (30 min at 200C), the slides were sealed in formolglycerol under a coverslip and examined in a standard Zeiss microscope with epi-illuminator and 63x oil phase contrast objective.
Only cells which by phase contract were considered as blastic or mononuclear were evaluated, and the frequency of stained nuclei was scored.
Results

Patients
The The difference in complete remission rate is statistically significant (P=0.001). There was also a significant difference (P = 0.007) between the two groups concerning survival as shown in Figure 3 . This difference was also found when patients under There are several previous reports on the prognostic value of TdT determinations in leukaemia Skoog et al., 1982; Marks et al., 1978; Mertlesman, 1982; Sasaki et al., 1981) . The majority of these studies have been on cells from patients with ALL and CML in blast crisis. In such cases TdT positivity indicates a high rate of responsiveness to chemotherapy Marks et al., 1978; Sasaki et al., 1981) . In an earlier study of AML we found that patients whose leukaemic cells have an increased level of TdT have both higher remission and survival rates (Skoog et al., 1982) . The number of patients was, however, small aid it was therefore of interest to confirm our findings on a larger group of patients.
The present article confirms that AML patients (<60 years) with high cellular levels of the enzyme have a significantly higher remission rate than those with low levels. These results are in contrast to those reported by Mertelsman (1982) who found that increased levels of TdT was correlated to a low remission rate and a shorter survival. In the latter study TdT positivity was defined in a semiquantitative way whereas our results are based on absolute values. This may partly explain the discrepancies observed although the biochemical background remains to be explored. Mertelsman (1982) also described that the presence of Auer rods in TdT negative patients was associated with an increased remission rate. In our material we were unable to attach any prognostic information to the finding of Auer rods.
There are several reports on the presence of glucocorticoid receptors in normal and neoplastic lymphoid and myeloid cells as well as in erythropoietic cells. In ALL high receptor levels appeared to be a prognostic favourable sign (Lippman et al., 1978; Sasaki et al., 1981) . In the case of AML conflicting results have been presented. Bell (1982) Unfortunately there are no antibodies available to the glucocorticoid receptor and it is thus not possible to show conclusively that the receptor as measured biochemically is located in all the leukaemic cells. When such antibodies are available it will be interesting to study the inter-and intracellular distribution in the leukaemic cells.
The levels of TdT and the glucocorticoid receptor may represent separate prognostic parameters. Thus, by combining both variables it was possible to show that patients with high levels of both TdT and the receptor had significantly higher remission rate and longer survival time as compared to those with low values of TdT and the receptor. A similar finding has been reported for patients with ALL and CML in blast crisis (Sasaki et al., 1981) . It is of interest to note that the remission rate and survival time did not correlate to other variables such as WBC, FAB subclass and the finding of Auer rods in our material. Although it is hard to explain the basis for prognostic prediction using TdT and the glucocorticoid receptor it is of importance to report such results since there are few good prognostic indicators in AML. It is possible that determinations of TdT and the glucocorticoid receptor can be of importance when planning new therapeutic strategies in the future. Furthermore it seems questionable if patients above 60 years of age with low TdT and low glucocorticoid receptor levels have any benefit from cytostatic drugs in the combinations and doses used in this series.
The results presented in this paper further stress the great heterogeneity of the AML which is a challenging field for future research.
